Project Details
Description
A Phase 3 Randomized Double-blind Trial of Maintenance with Niraparib versus Placebo in Patients with Platinum Sensitive Ovarian Cancer
| Status | Finished |
|---|---|
| Effective start/end date | 8/1/13 → 5/4/17 |
Funding
- TESARO, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.